probenecid has been researched along with Ache in 2 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bang, S | 1 |
Kim, KY | 1 |
Yoo, S | 1 |
Lee, SH | 1 |
Hwang, SW | 1 |
Cosi, C | 1 |
Mannaioni, G | 1 |
Cozzi, A | 1 |
CarlĂ , V | 1 |
Sili, M | 1 |
Cavone, L | 1 |
Maratea, D | 1 |
Moroni, F | 1 |
2 other studies available for probenecid and Ache
Article | Year |
---|---|
Transient receptor potential V2 expressed in sensory neurons is activated by probenecid.
Topics: Adjuvants, Pharmaceutic; Animals; Boron Compounds; Calcium Channels; Cell Line; Cell Size; Gene Expr | 2007 |
G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: Studies on the antinociceptive effects of kynurenic acid and zaprinast.
Topics: Analgesics; Animals; Antidepressive Agents, Second-Generation; Dose-Response Relationship, Drug; Dru | 2011 |